Will Rivaroxaban Be Cost-Effective for Prevention. of Venous Thromboembolism after Total Hip Replacement in US Patients?.

被引：0
|
作者：
Kwong, Louis [1 ]
Diamantopoulos, Alexander [2 ]
Forster, Fiona [2 ]
Sengupta, Nishan
Lees, Michael [3 ]
机构：
[1] Harbor UCLA Med Ctr, Torrance, CA 90509 USA
[2] IMS Hlth, London, England
[3] Bayer PLC, Uxbridge, Middx, England
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：467 / 467
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS ANALYSIS OF RIVAROXABAN IN PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP REPLACEMENT IN SLOVAKIA
    Lukac, M.
    Bielik, J.
    Lees, M.
    Foltan, V
    Tomek, D.
    VALUE IN HEALTH, 2010, 13 (07) : A520 - A520
  • [2] COST-UTILITY ANALYSIS OF RIVAROXABAN COMPARED WITH ENOXAPARIN IN PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP REPLACEMENT IN SLOVAKIA
    Pereira, R.
    Diamantopoulos, A.
    Bielik, J.
    Lees, M.
    Tomek, D.
    Lukac, M.
    VALUE IN HEALTH, 2010, 13 (03) : A166 - A166
  • [3] COST-EFFECTIVENESS ANALYSIS OF RIVAROXABAN VERSUS DABIGATRAN AND ENOXAPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP REPLACEMENT
    Vorobyev, P.
    Krasnova, L.
    Borisenko, O.
    Lukyantseva, D.
    Bashlakova, E.
    VALUE IN HEALTH, 2011, 14 (03) : A40 - A40
  • [4] COST-EFFECTIVENESS OF RIVAROXABAN VERSUS ENOXAPARIN FOR PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP AND KNEE REPLACEMENT IN EUROPE
    Monreal, M.
    Ryttberg, L.
    Diamantopoulos, A.
    Lees, M.
    Negrini, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 50 - 51
  • [5] Cost-effectiveness of rivaroxaban for prevention of venous thromboembolism (VTE) after total hip or knee replacement (THR, TKR) in the USA
    Kwong, L.
    Duran, A.
    Diamantopoulos, A.
    Sengupta, N.
    Lees, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 787 - 787
  • [6] Rivaroxaban A Review of its Use for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement Surgery
    Duggan, Sean T.
    Scott, Lesley J.
    Plosker, Greg L.
    DRUGS, 2009, 69 (13) : 1829 - 1851
  • [7] COST-EFFECTIVENESS OF RIVAROXABAN VERSUS ENOXAPARIN FOR PREVENTION OF VENOUS THROMBOEMBOLISM (VTE) AFTER TOTAL HIP AND KNEE REPLACEMENT (THR, TKR) IN CHINESE PATIENTS
    Chen, X. B.
    Eggington, S.
    Wang, C. Y.
    Zhu, M.
    VALUE IN HEALTH, 2010, 13 (07) : A520 - A520
  • [8] Economic Evaluation of Rivaroxaban Versus Enoxaparin for Prevention of Venous Thromboembolism After Total Knee Replacement and Total Hip Replacement: A Systematic Review
    Asma Rashki Kemmak
    Ali Abutorabi
    Vahid Alipour
    Clinical Drug Investigation, 2020, 40 : 715 - 725
  • [9] Economic Evaluation of Rivaroxaban Versus Enoxaparin for Prevention of Venous Thromboembolism After Total Knee Replacement and Total Hip Replacement: A Systematic Review
    Rashki Kemmak, Asma
    Abutorabi, Ali
    Alipour, Vahid
    CLINICAL DRUG INVESTIGATION, 2020, 40 (08) : 715 - 725
  • [10] Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement
    Eriksson, B. I.
    Kakkar, A. K.
    Turpie, A. G. G.
    Gent, M.
    Bandel, T. -J.
    Homering, M.
    Misselwitz, F.
    Lassen, M. R.
    JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2009, 91B (05): : 636 - 644
12345